COVID-19 Myocarditis Clinical Presentation, Diagnosis and Management: A Narrative Review

Zaghrini, Elie Al; Emmanuel, Nancy; Zibara, Victor; Terro, Wael; Hanna, Steven

doi:10.38179/ijcr.v1i1.27

Cited by 3 publications

(2 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, those who have torsades de pointes risk and are treated with drugs for QTc prolongation should be monitored by telemetry, and an electrocardiogram should be performed [130]. Above all, in order to minimize the viral transmission risk, the utility of diagnostic modalities (endomyocardial biopsies, invasive hemodynamic assessments, and cardiac imaging) should be considered carefully [131,132]. The preferred approach for most patients with ST-segment elevation MI is primary percutaneous coronary intervention.…”

Section: Management Considerationsmentioning

confidence: 99%

Atypical Complications during the Course of COVID-19: A Comprehensive Review

Mallhi,

Safdar,

Butt

et al. 2024

Medicina

View full text Add to dashboard Cite

COVID-19 is primarily a respiratory disease, but numerous studies have indicated the involvement of various organ systems during the course of illness. We conducted a comprehensive review of atypical complications of COVID-19 with their incidence range (IR) and their impact on hospitalization and mortality rates. We identified 97 studies, including 55 research articles and 42 case studies. We reviewed four major body organ systems for various types of atypical complications: (i) Gastro-intestinal (GI) and hepatobiliary system, e.g., bowel ischemia/infarction (IR: 1.49–83.87%), GI bleeding/hemorrhage (IR: 0.47–10.6%), hepatic ischemia (IR: 1.0–7.4%); (ii) Neurological system, e.g., acute ischemic stroke/cerebral venous sinus thrombosis/cerebral hemorrhage (IR: 0.5–90.9%), anosmia (IR: 4.9–79.6%), dysgeusia (IR: 2.8–83.38%), encephalopathy/encephalitis with or without fever and hypoxia (IR: 0.19–35.2%); (iii) Renal system, e.g., acute kidney injury (AKI)/acute renal failure (IR: 0.5–68.8%); (iv) Cardiovascular system, e.g., acute cardiac injury/non-coronary myocardial injury (IR: 7.2–55.56%), arrhythmia/ventricular tachycardia/ventricular fibrillation (IR: 5.9–16.7%), and coagulopathy/venous thromboembolism (IR: 19–34.4%). This review encourages and informs healthcare practitioners to keenly monitor COVID-19 survivors for these atypical complications in all major organ systems and not only treat the respiratory symptoms of patients. Post-COVID effects should be monitored, and follow-up of patients should be performed on a regular basis to check for long-term complications.

show abstract

Section: Management Considerationsmentioning

confidence: 99%

Atypical Complications during the Course of COVID-19: A Comprehensive Review

Mallhi,

Safdar,

Butt

et al. 2024

Medicina

View full text Add to dashboard Cite

show abstract

“…Conversely, COVID-19 could be the inciting factor of HF. Several articles, discussed previously, described the association between COVID-19 and myocarditis [7,8,18,21,22]. Cardiac injury secondary to myocarditis could predispose the patient to congestive HF [23].…”

Section: Cardiovascular Disease and Diabetesmentioning

confidence: 99%

SARS, MERS, COVID-19: Identification of Patients at a Higher Risk: A Narrative Review

et al. 2021

View full text Add to dashboard Cite

The different presentations, comorbidities, and outcomes of COVID-19 highlight the importance of early identification and proper triage of patients. High-risk patients can be divided into patients with common comorbidities and patients with special categories. Common comorbidities include, but are not limited to, Cardiovascular Disease (CVD), Diabetes Mellitus (DM), immunosuppression, underlying respiratory disease, and obesity. Certain categories of COVID-19 patients are also at increased risk, including neonates and pregnant women. In the present article, we delineate the reported risk factors for acquisition of infection, and for increased severity of the clinical disease. We also comparatively analyze those risk factors associated with COVID-19 and with the antecedent human acute respiratory syndrome-causing viruses, SARS-CoV-1 and MERS-CoV. We hypothesize that the structural similarities of the three viruses predict a similarity in the profile of high-risk patients. Several pathophysiological patterns have been detected to support this theory.

show abstract

Differential diagnosis of myocardial infarction and myopericarditis during a pandemic

et al. 2021

View full text Add to dashboard Cite

Difficulties in the differential diagnosis of non-ST-elevation myocardial infarction (NSTEMI) and acute myopericarditis during the novel coronavirus infection (COVID-19) pandemic appear to be a relevant and interesting issue.We present a clinical case of a 55-year-old female patient with an atypical presentation of NSTEMI. Initially, the disease resembles an acute viral infection. It was known that the patient came in contact with COVID-19 infection. Taking into account that the patient had dull left chest pain unrelated to physical activities, low-grade fever, elevated levels of troponin T and acute phase reactants, absence of wall motion abnormalities, the patient was assessed as having acute viral myopericarditis. Contrastenhanced cardiac magnetic resonance imaging (MRI) showed signs of myocardial infarction. Coronary angiography confirmed myocardial infarction and the patient underwent percutaneous coronary intervention (PCI). In the article we discuss the value of electrocardiography (ECG), echocardiography and MRI in the NSTEMI diagnosis, and also additional difficulties in the COVID-19 pandemic era. Due to high probability of myopericarditis the patient received non-steroidal anti-inflammatory drugs instead of optimal medical therapy and early PCI. Our clinical case demonstrates that despite of COVID-19 pandemic significant elevation of troponin level requires adherence to the acute myocardial infarction algorithm.

show abstract

COVID-19 Myocarditis Clinical Presentation, Diagnosis and Management: A Narrative Review

Cited by 3 publications

References 35 publications

Atypical Complications during the Course of COVID-19: A Comprehensive Review

Atypical Complications during the Course of COVID-19: A Comprehensive Review

SARS, MERS, COVID-19: Identification of Patients at a Higher Risk: A Narrative Review

Differential diagnosis of myocardial infarction and myopericarditis during a pandemic

Contact Info

Product

Resources

About